US Stock MarketDetailed Quotes

PMCB PharmaCyte Biotech

Watchlist

1.640
0.0000.00%

Close Dec 20 16:00 ET

11.43MMarket Cap1.86P/E (TTM)

PharmaCyte Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Oct 31, 2024

(Q1)Jul 31, 2024

(FY)Apr 30, 2024

(Q4)Apr 30, 2024

(Q3)Jan 31, 2024

(Q2)Oct 31, 2023

(Q1)Jul 31, 2023

(FY)Apr 30, 2023

(Q4)Apr 30, 2023

(Q3)Jan 31, 2023

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-21.53%1.11M

-38.86%1.27M

1.00%6.52M

29.11%1.17M

20.35%1.87M

-39.21%1.41M

23.49%2.08M

46.98%6.46M

-40.09%903.28K

81.40%1.55M

Selling and administrative expenses

-33.97%725.26K

-54.74%783.39K

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

-General and administrative expense

-33.97%725.26K

-54.74%783.39K

0.80%4.79M

49.35%839.55K

-10.72%1.12M

-36.89%1.1M

45.01%1.73M

120.37%4.75M

10.25%562.15K

191.44%1.26M

Research and development costs

18.82%97.47K

-8.10%96.02K

-13.04%407.43K

9.68%94.18K

179.19%126.73K

-53.91%82.03K

-34.40%104.48K

-32.19%468.54K

-66.20%85.87K

-71.28%45.39K

Other operating expenses

23.64%283.33K

62.29%389.48K

7.08%1.32M

-8.92%232.48K

146.77%620.78K

-42.77%229.16K

-26.77%240K

-20.05%1.23M

-65.68%255.26K

-5.82%251.56K

Operating profit

21.53%-1.11M

38.86%-1.27M

-1.00%-6.52M

-29.11%-1.17M

-20.35%-1.87M

39.21%-1.41M

-23.49%-2.08M

-46.98%-6.46M

40.09%-903.28K

-81.40%-1.55M

Net non-operating interest income expense

-57.22%382.56K

-37.50%547.43K

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,133.01%1.94M

735.12%722.94K

1,298.82%635.89K

Non-operating interest income

-57.22%382.56K

-37.50%547.43K

75.42%3.4M

3.34%747.1K

38.65%881.66K

103.61%894.18K

527.86%875.88K

1,129.03%1.94M

735.12%722.94K

1,298.82%635.89K

Other net income (expense)

-122.57%-746.06K

1,316.97%24.14M

1,610.36%3.45M

3,169.55%1.77M

140.42%367.75K

312,504.06%3.31M

-50,689.78%-1.98M

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

Gain on sale of security

-122.53%-745K

1,318.11%24.14M

--3.49M

--1.8M

--368K

--3.31M

---1.98M

----

Special income (charges)

----

---3.57M

----

--0

----

-Less:Impairment of capital assets

----

--2M

----

--0

----

-Write off

----

--1.57M

----

--0

----

Other non- operating income (expenses)

-38.82%-1.06K

89.72%-190

1,649.56%3.53M

6,449.05%3.54M

-100.17%-253

27.69%-765

52.66%-1.85K

4,816.37%202K

3,533.44%54.01K

24,379.05%152.96K

Income before tax

-152.67%-1.47M

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

Income tax

Net income

-152.67%-1.47M

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

Net income continuous Operations

-152.67%-1.47M

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

Minority interest income

Net income attributable to the parent company

-152.67%-1.47M

835.76%23.42M

107.73%333.76K

1,165.95%1.35M

18.92%-619.54K

248.36%2.79M

-106.04%-3.18M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

Preferred stock dividends

-24.35%443.96K

114.41%685.8K

2.52M

829.4K

781.51K

586.89K

319.85K

Other preferred stock dividends

-76.57%1.05M

-34.35%2.15M

15.05M

3.06M

4.22M

4.46M

3.27M

Net income attributable to common stockholders

-31.03%-2.96M

403.87%20.59M

-299.38%-17.24M

-1,910.91%-2.54M

-635.49%-5.62M

-20.08%-2.26M

-338.52%-6.78M

-1.81%-4.32M

91.12%-126.34K

5.81%-764.14K

Basic earnings per share

-50.00%-0.39

451.85%1.9

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-671.43%-0.54

18.52%-0.22

83.33%-0.01

0.00%-0.04

Diluted earnings per share

-50.00%-0.39

451.85%1.9

-718.18%-1.8

-3,200.00%-0.33

-1,525.00%-0.65

-188.89%-0.26

-671.43%-0.54

18.52%-0.22

83.33%-0.01

0.00%-0.04

Dividend per share

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q2)Oct 31, 2024	(Q1)Jul 31, 2024	(FY)Apr 30, 2024	(Q4)Apr 30, 2024	(Q3)Jan 31, 2024	(Q2)Oct 31, 2023	(Q1)Jul 31, 2023	(FY)Apr 30, 2023	(Q4)Apr 30, 2023	(Q3)Jan 31, 2023
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-21.53%1.11M	-38.86%1.27M	1.00%6.52M	29.11%1.17M	20.35%1.87M	-39.21%1.41M	23.49%2.08M	46.98%6.46M	-40.09%903.28K	81.40%1.55M
Selling and administrative expenses	-33.97%725.26K	-54.74%783.39K	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M
-General and administrative expense	-33.97%725.26K	-54.74%783.39K	0.80%4.79M	49.35%839.55K	-10.72%1.12M	-36.89%1.1M	45.01%1.73M	120.37%4.75M	10.25%562.15K	191.44%1.26M
Research and development costs	18.82%97.47K	-8.10%96.02K	-13.04%407.43K	9.68%94.18K	179.19%126.73K	-53.91%82.03K	-34.40%104.48K	-32.19%468.54K	-66.20%85.87K	-71.28%45.39K
Other operating expenses	23.64%283.33K	62.29%389.48K	7.08%1.32M	-8.92%232.48K	146.77%620.78K	-42.77%229.16K	-26.77%240K	-20.05%1.23M	-65.68%255.26K	-5.82%251.56K
Operating profit	21.53%-1.11M	38.86%-1.27M	-1.00%-6.52M	-29.11%-1.17M	-20.35%-1.87M	39.21%-1.41M	-23.49%-2.08M	-46.98%-6.46M	40.09%-903.28K	-81.40%-1.55M
Net non-operating interest income expense	-57.22%382.56K	-37.50%547.43K	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,133.01%1.94M	735.12%722.94K	1,298.82%635.89K
Non-operating interest income	-57.22%382.56K	-37.50%547.43K	75.42%3.4M	3.34%747.1K	38.65%881.66K	103.61%894.18K	527.86%875.88K	1,129.03%1.94M	735.12%722.94K	1,298.82%635.89K
Other net income (expense)	-122.57%-746.06K	1,316.97%24.14M	1,610.36%3.45M	3,169.55%1.77M	140.42%367.75K	312,504.06%3.31M	-50,689.78%-1.98M	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K
Gain on sale of security	-122.53%-745K	1,318.11%24.14M	--3.49M	--1.8M	--368K	--3.31M	---1.98M	----	----	----
Special income (charges)	----	----	---3.57M	----	----	----	----	--0	----	----
-Less:Impairment of capital assets	----	----	--2M	----	----	----	----	--0	----	----
-Write off	----	----	--1.57M	----	----	----	----	--0	----	----
Other non- operating income (expenses)	-38.82%-1.06K	89.72%-190	1,649.56%3.53M	6,449.05%3.54M	-100.17%-253	27.69%-765	52.66%-1.85K	4,816.37%202K	3,533.44%54.01K	24,379.05%152.96K
Income before tax	-152.67%-1.47M	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K
Income tax
Net income	-152.67%-1.47M	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K
Net income continuous Operations	-152.67%-1.47M	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K
Minority interest income
Net income attributable to the parent company	-152.67%-1.47M	835.76%23.42M	107.73%333.76K	1,165.95%1.35M	18.92%-619.54K	248.36%2.79M	-106.04%-3.18M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K
Preferred stock dividends	-24.35%443.96K	114.41%685.8K	2.52M	829.4K	781.51K	586.89K	319.85K
Other preferred stock dividends	-76.57%1.05M	-34.35%2.15M	15.05M	3.06M	4.22M	4.46M	3.27M	0	0	0
Net income attributable to common stockholders	-31.03%-2.96M	403.87%20.59M	-299.38%-17.24M	-1,910.91%-2.54M	-635.49%-5.62M	-20.08%-2.26M	-338.52%-6.78M	-1.81%-4.32M	91.12%-126.34K	5.81%-764.14K
Basic earnings per share	-50.00%-0.39	451.85%1.9	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-671.43%-0.54	18.52%-0.22	83.33%-0.01	0.00%-0.04
Diluted earnings per share	-50.00%-0.39	451.85%1.9	-718.18%-1.8	-3,200.00%-0.33	-1,525.00%-0.65	-188.89%-0.26	-671.43%-0.54	18.52%-0.22	83.33%-0.01	0.00%-0.04
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Heat List

Overall

No Data